Roundup: Tranexamic Acid for Intracerebral Hemorrhage, Low DOAC Adherence, and More

Think you may have missed any of this month’s top stories? Here’s our highlight reel of top anticoagulation news that broke during the month of May.

New research suggests that tranexamic acid —commonly used to prevent bleeding after trauma or postpartum hemorrhage—may improve outcomes after intracerebral hemorrhage.

This finding emerged from a study of 2325 participants from acute stroke units at 124 hospitals across 12 countries. Read More

As many as one-third of patients receiving direct oral anticoagulant therapy do not maintain adherence above 80%, according to a new study.

As a result, these patients have an increased risk of thromboembolic events. Read More

The prevalence of atrial fibrillation-associated acute ischemic stroke has risen in the United States in recent years.

To see which patient populations are most affected, read more.

SEE ALSO:

Q&A: 6 Questions on Anticoagulation Therapy for AFib With Dr Wesley O’Neal

Consultant360 recently spoke with Dr O’Neal regarding his latest research about the link between provider specialty, anticoagulation prescription patterns, and stroke risk in patients with atrial fibrillation. Read More

Podcast: Omega 3s Improve Cardio Health

Dr Kevin Maki, president and chief science officer at Midwest Biomedical Research, speaks to us about his latest review about the effect of omega3 supplementation on cardiometabolic health.